<p>Comparison of serum NSE levels between small cell lung cancer group and control group.</p
<p>Comparison of all-cause mortality between the screening and clinical detection groups among patie...
Comparison of laboratory parameters of SFTS patients in the survivor and non-survivor groups.</p
<p>Subgroup analysis of lung cancer for folate intake versus the lowest intake.</p
Serum NSE levels were investigated in the healthy population and in patients with lung cancer. Consi...
<p>Comparison of general characteristics and serum lipids levels between the control and case groups...
<p>Comparison of the biomarkers between the patients with OPLL (case) and the controls.</p
<p>Comparison of the reactivity with peptide NTM1 of sera from cancer patients, athletes and healthy...
<p>Correlation between NSE level in MM patients and progression-free survival (PFS).</p
<p>Correlation between NSE level and the amount of prognostic indicator β2-MG in MM patients after r...
<p>Comparison of scores of SCL 90 between oral cancer and oral benign tumor groups.</p
<p><b>(A)</b> csCEA group; <b>(B)</b> eCEA group; *—significant compared to pre-clamp (P<0.01); † - ...
<p>Median values are indicated by short horizontal lines, whereas samples with levels below the limi...
<p>Serum levels of <b>(A)</b> BCHE and <b>(B)</b> GPx3 in the control and NSCLC groups. <b>(C)</b> R...
Background and objective It has been proven that neuron specific enolase (NSE) was one of the sensit...
<p>Comparison of the characteristics of lung cancer patients with or without sarcopenia.</p
<p>Comparison of all-cause mortality between the screening and clinical detection groups among patie...
Comparison of laboratory parameters of SFTS patients in the survivor and non-survivor groups.</p
<p>Subgroup analysis of lung cancer for folate intake versus the lowest intake.</p
Serum NSE levels were investigated in the healthy population and in patients with lung cancer. Consi...
<p>Comparison of general characteristics and serum lipids levels between the control and case groups...
<p>Comparison of the biomarkers between the patients with OPLL (case) and the controls.</p
<p>Comparison of the reactivity with peptide NTM1 of sera from cancer patients, athletes and healthy...
<p>Correlation between NSE level in MM patients and progression-free survival (PFS).</p
<p>Correlation between NSE level and the amount of prognostic indicator β2-MG in MM patients after r...
<p>Comparison of scores of SCL 90 between oral cancer and oral benign tumor groups.</p
<p><b>(A)</b> csCEA group; <b>(B)</b> eCEA group; *—significant compared to pre-clamp (P<0.01); † - ...
<p>Median values are indicated by short horizontal lines, whereas samples with levels below the limi...
<p>Serum levels of <b>(A)</b> BCHE and <b>(B)</b> GPx3 in the control and NSCLC groups. <b>(C)</b> R...
Background and objective It has been proven that neuron specific enolase (NSE) was one of the sensit...
<p>Comparison of the characteristics of lung cancer patients with or without sarcopenia.</p
<p>Comparison of all-cause mortality between the screening and clinical detection groups among patie...
Comparison of laboratory parameters of SFTS patients in the survivor and non-survivor groups.</p
<p>Subgroup analysis of lung cancer for folate intake versus the lowest intake.</p
DOI
Add to ORKG